AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

被引:1355
作者
Anzick, SL
Kononen, J
Walker, RL
Azorsa, DO
Tanner, MM
Guan, XY
Sauter, G
Kallioniemi, OP
Trent, JM
Meltzer, PS
机构
[1] NATL HUMAN GENOME RES INST,CANC GENET LAB,NIH,BETHESDA,MD 20892
[2] UNIV TAMPERE,INST MED TECHNOL,CANC GENET LAB,FIN-33101 TAMPERE,FINLAND
[3] TAMPERE UNIV HOSP,FIN-33101 TAMPERE,FINLAND
[4] UNIV BASEL,INST PATHOL,CH-4003 BASEL,SWITZERLAND
关键词
D O I
10.1126/science.277.5328.965
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Members of the recently recognized SRC-1 family of transcriptional coactivators interact with steroid hormone receptors to enhance ligand-dependent transcription. AIB1, a member of the SRC-1 family, was cloned during a search on the long arm of chromosome 20 for genes whose expression and copy number were elevated in human breast cancers. AIB1 amplification and overexpression were observed in four of five estrogen receptor-positive breast and ovarian cancer cell lines. Subsequent evaluation of 105 unselected specimens of primary breast cancer found AIB1 amplification in approximately 10 percent and high expression in 64 percent of the primary tumors analyzed. AIB1 protein interacted with estrogen receptors in a ligand-dependent fashion, and transfection of AIB1 resulted in enhancement of estrogen-dependent transcription, These observations identify AIB1 as a nuclear receptor coactivator whose altered expression may contribute to development of steroid-dependent cancers.
引用
收藏
页码:965 / 968
页数:4
相关论文
共 21 条
  • [11] THE N-TERMINAL PART OF TIF1, A PUTATIVE MEDIATOR OF THE LIGAND-DEPENDENT ACTIVATION FUNCTION (AF-2) OF NUCLEAR RECEPTORS, IS FUSED TO B-RAF IN THE ONCOGENIC PROTEIN T18
    LEDOUARIN, B
    ZECHEL, C
    GARNIER, JM
    LUTZ, Y
    TORA, L
    PIERRAT, B
    HEERY, D
    GRONEMEYER, H
    CHAMBON, P
    LOSSON, R
    [J]. EMBO JOURNAL, 1995, 14 (09) : 2020 - 2033
  • [12] DETECTION OF DNA AMPLIFICATION IN 17 PRIMARY BREAST CARCINOMAS WITH HOMOGENEOUSLY STAINING REGIONS BY A MODIFIED COMPARATIVE GENOMIC HYBRIDIZATION TECHNIQUE
    MULERIS, M
    ALMEIDA, A
    GERBAULTSEUREAU, M
    MALFOY, B
    DUTRILLAUX, B
    [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (03) : 160 - 170
  • [13] ONATE SA, 1995, SCIENCE, V270, P1354
  • [14] CYTOGENETIC ANALYSIS USING QUANTITATIVE, HIGH-SENSITIVITY, FLUORESCENCE HYBRIDIZATION
    PINKEL, D
    STRAUME, T
    GRAY, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) : 2934 - 2938
  • [15] Sallinen P, 1997, AM J PATHOL, V150, P1159
  • [16] Sambrook J., 2002, MOL CLONING LAB MANU
  • [17] TANNER MM, 1994, CANCER RES, V54, P4257
  • [18] Tanner MM, 1996, CANCER RES, V56, P3441
  • [19] The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
    Torchia, J
    Rose, DW
    Inostroza, J
    Kamei, Y
    Westin, S
    Glass, CK
    Rosenfeld, MG
    [J]. NATURE, 1997, 387 (6634) : 677 - 684
  • [20] TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
    Voegel, JJ
    Heine, MJS
    Zechel, C
    Chambon, P
    Gronemeyer, H
    [J]. EMBO JOURNAL, 1996, 15 (14) : 3667 - 3675